These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10085605)
1. [Clinical use of a quadruple biochemical marker in the prediction of obstetric complications]. Aranda Gallegos JE; Barrón Vallejo J; de la Luna Pérez LG; Corona de Lau QC; Kably Ambe A Ginecol Obstet Mex; 1999 Jan; 67():18-22. PubMed ID: 10085605 [TBL] [Abstract][Full Text] [Related]
2. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
4. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Wald NJ; Morris JK; Ibison J; Wu T; George LM Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087 [TBL] [Abstract][Full Text] [Related]
5. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital. Lamlertkittikul S; Chandeying V J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. Odibo AO; Sehdev HM; Stamilio DM; Macones GA Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275 [TBL] [Abstract][Full Text] [Related]
9. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening. Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324 [TBL] [Abstract][Full Text] [Related]
10. Biochemical assessment and prediction of gestational well-being. Martin JN; Cowan BD Obstet Gynecol Clin North Am; 1990 Mar; 17(1):81-93. PubMed ID: 1694021 [TBL] [Abstract][Full Text] [Related]
11. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women. Sritippayawan S; Vachirasrisoontra C J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246 [TBL] [Abstract][Full Text] [Related]
12. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]. Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497 [TBL] [Abstract][Full Text] [Related]
13. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
14. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives]. Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058 [TBL] [Abstract][Full Text] [Related]
16. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis. Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989 [TBL] [Abstract][Full Text] [Related]
17. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Huttly W; Rudnicka A; Wald NJ Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275 [TBL] [Abstract][Full Text] [Related]
18. [Specificity of biochemical markers of pregnancy second trimester]. Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy and delivery outcomes following a pathological second trimester triple test screening result and a normal karyotype. Weintraub AY; Weiss I; Friger M; Hershkovitz R J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2606-9. PubMed ID: 22873284 [TBL] [Abstract][Full Text] [Related]